Marek’s disease (MD) and infectious bursal disease (IBD) are highly infectious diseases of poultry that provide constant threat to the productivity of the worldwide poultry industry through their associated high mortality rates. Researchers at The Pirbright Institute have developed a new recombinant viral vector-based vaccine that is effective against both MD and IDB.
News from June 2018
Researchers at The Pirbright Institute have helped in the development of a new molecule to treat a range of viruses including the common cold. In addition to the days of work lost due to illness, the common cold can cause complications in respiratory illnesses such as asthma and cystic fibrosis.